Identifying miRNA Modules and Related Pathways of Chronic Obstructive Pulmonary Disease Associated Emphysema by Weighted Gene Co-Expression Network Analysis

References

• Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet. 2017;389:1931‐1940. doi:10.1016/S0140-6736(17)31222-9
   PubMed Web of Science ®Google Scholar
• McLean S, Hoogendoorn M, Hoogenveen RT, et al. Projecting the COPD population and costs in England and Scotland: 2011 to 2030. Sci Rep. 2016;6:31893. doi:10.1038/srep31893
   PubMed Web of Science ®Google Scholar
• Regan EA, Lynch DA, Curran-Everett D, et al. Clinical and radiologic disease in smokers with normal spirometry. JAMA Intern Med. 2015;175:1539–1549. doi:10.1001/jamainternmed.2015.2735
   PubMed Web of Science ®Google Scholar
• Celli BR, Decramer M, Wedzicha JA, et al. An official American Thoracic Society/European Respiratory Society statement: research questions in COPD. Eur Respir Rev. 2015;24:159–172. doi:10.1183/16000617.00000315
   PubMed Web of Science ®Google Scholar
• McCloskey SC, Patel BD, Hinchliffe SJ, et al. Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction. Am J Respir Crit Care Med. 2001;164:1419–1424. doi:10.1164/ajrccm.164.8.2105002
   PubMed Web of Science ®Google Scholar
• Hunninghake GM, Cho MH, Tesfaigzi Y, et al. MMP12, lung function, and COPD in high-risk populations. N Engl J Med. 2009;361(27):2599–2608. doi:10.1056/NEJMoa0904006
   PubMed Web of Science ®Google Scholar
• Ding Z, Wang K, Li J, et al. Association between glutathione S-transferase gene M1 and T1 polymorphisms and chronic obstructive pulmonary disease risk: a meta-analysis. Clin Genet. 2019;95(1):53–62. doi:10.1111/cge.13373
   PubMed Web of Science ®Google Scholar
• Cho MH, Boutaoui N, Klanderman BJ, et al. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet. 2010;42(3):200–202. doi:10.1038/ng.535
   PubMed Web of Science ®Google Scholar
• Pillai SG, Ge D, Zhu G, et al. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet. 2009;5(3):e1000421. doi:10.1371/journal.pgen.1000421
   PubMed Web of Science ®Google Scholar
• Soler Artigas M, Wain LV, Repapi E, et al. Effect of five genetic variants associated with lung function on the risk of chronic obstructive lung disease, and their joint effects on lung function. Am J Respir Crit Care Med. 2011;184(7):786–795. doi:10.1164/rccm.201102-0192OC
   PubMed Web of Science ®Google Scholar
• Repapi E, Sayers I, Wain LV, et al. Genome-wide association study identifies five loci associated with lung function. Nat Genet. 2010;42(1):36–44. doi:10.1038/ng.501
   PubMed Web of Science ®Google Scholar
• Han J, Lee Y, Yeom KH, et al. Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell. 2006;125(5):887–901. doi:10.1016/j.cell.2006.03.043
   PubMed Web of Science ®Google Scholar
• Lund E, Guttinger S, Calado A, et al. Nuclear export of microRNA precursors. Science. 2004;303(15):95–98. doi:10.1126/science.1090599
   PubMedGoogle Scholar
• Ambros V. The functions of animal microRNA s. Nature. 2004;431:350‑355. doi:10.1038/nature02871
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281‑297. doi:10.1016/s0092-8674(04)00045-5
   PubMed Web of Science ®Google Scholar
• Cao Z, Zhang N, Lou T, et al. microRNA-183 down-regulates the expression of BKCaβ1 protein that is related to the severity of chronic obstructive pulmonary disease. Hippokratia. 2014;18(4):328–332.
   PubMed Web of Science ®Google Scholar
• Donaldson A, Natanek SA, Lewis A, et al. Increased skeletal muscle-specific microRNA in the blood of patients with COPD. Thorax. 2013;68:1140–1149. doi:10.1136/thoraxjnl-2012-203129
   PubMed Web of Science ®Google Scholar
• Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008;9:559. doi:10.1186/1471-2105-9-559
   PubMed Web of Science ®Google Scholar
• Carlson MR, Zhang B, Fang Z, et al. Gene connectivity, function, and sequence conservation: predictions from modular yeast co-expression networks. BMC Genomics. 2006;7:40. doi:10.1186/1471-2164-7-40
   PubMed Web of Science ®Google Scholar
• Carter SL, Brechbuhler CM, Griffin M, et al. Gene co-expression network topology provides a framework for molecular characterization of cellular state. Bioinformatics. 2004;20(14):2242–2250. doi:10.1093/bioinformatics/bth234
   PubMed Web of Science ®Google Scholar
• Wan Q, Tang J, Han Y, et al. Co-expression modules construction by WGCNA and identify potential prognostic markers of uveal melanoma. Exp Eye Res. 2018;166:13–20. doi:10.1016/j.exer.2017.10.007
   PubMed Web of Science ®Google Scholar
• Zhai X, Xue Q, Liu Q, et al. Colon cancer recurrence-associated genes revealed by WGCNA coexpression network analysis. Mol Med Rep. 2017;16:6499–6505. doi:10.3892/mmr.2017.7412
   PubMed Web of Science ®Google Scholar
• Liu R, Zhang W, Liu ZQ, et al. Associating transcriptional modules with colon cancer survival through weighted gene co-expression network analysis. BMC Genomics. 2017;18:361. doi:10.1186/s12864-017-3761-z
   PubMed Web of Science ®Google Scholar
• Qin J, Yang T, Zeng N, et al. Differential coexpression networks in bronchiolitis and emphysema phenotypes reveal heterogeneous mechanisms of chronic obstructive pulmonary disease. J Cell Mol Med. 2019;23(10):6989–6999. doi:10.1111/jcmm.14585
   PubMed Web of Science ®Google Scholar
• Savarimuthu Francis SM, Davidson MR, Tan ME, et al. MicroRNA-34c is associated with emphysema severity and modulates SERPINE1 expression. BMC Genomics. 2014;15:88. doi:10.1186/1471-2164-15-88
   PubMed Web of Science ®Google Scholar
• Francis SM, Larsen JE, Pavey SJ, et al. Expression profiling identifies genes involved in emphysema severity. Respir Res. 2009;10(1):81. doi:10.1186/1465-9921-10-81
   PubMedGoogle Scholar
• Langfelder P, Horvath S. Fast R functions for robust correlations and hierarchical clustering. J Stat Softw. 2012;46(11):11.
   Web of Science ®Google Scholar
• Xu P, Yang J, Liu J, et al. Identification of glioblastoma gene prognosis modules based on weighted gene co-expression network analysis. BMC Med Genomics. 2018;11(1):96. doi:10.1186/s12920-018-0407-1
   PubMedGoogle Scholar
• Langfelder P, Horvath S. Eigengene networks for studying the relationships between co-expression modules. BMC Syst Biol. 2007;1:54. doi:10.1186/1752-0509-1-54
   PubMed Web of Science ®Google Scholar
• Zhang B, Horvath S. A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol. 2005;4:17. doi:10.2202/1544-6115.1128
   PubMed Web of Science ®Google Scholar
• Russell SA, Bashaw GJ. Axon guidance pathways and the control of gene expression. Dev Dyn. 2018;247(4):571–580. doi:10.1002/dvdy.24609
   PubMed Web of Science ®Google Scholar
• Li HS, Chen JH, Wu W, et al. Vertebrate slit, a secreted ligand for the transmembrane protein roundabout, is a repellent for olfactory bulb axons. Cell. 1999;96(6):807–818. doi:10.1016/s0092-8674(00)80591-7
   PubMed Web of Science ®Google Scholar
• Tole S, Mukovozov IM, Huang YW, et al. The axonal repellent, Slit2, inhibits directional migration of circulating neutrophils. J Leukoc Biol. 2009;86(6):1403–1415. doi:10.1189/jlb.0609391
   PubMed Web of Science ®Google Scholar
• Lin YZ, Zhong XN, Chen X, Liang Y, Zhang H, Zhu DL. Roundabout signaling pathway involved in the pathogenesis of COPD by integrative bioinformatics analysis. Int J Chron Obstruct Pulmon Dis. 2019;14:2145–2162. doi:10.2147/COPD.S216050
   PubMed Web of Science ®Google Scholar
• He CW, Liao CP, Pan CL. Wnt signalling in the development of axon, dendrites and synapses. Open Biol. 2018;8(10):180116. doi:10.1098/rsob.180116
   PubMed Web of Science ®Google Scholar
• Qu J, Yue L, Gao J, Yao H. Perspectives on Wnt signal pathway in the pathogenesis and therapeutics of chronic obstructive pulmonary disease. J Pharmacol Exp Ther. 2019;369(3):473–480. doi:10.1124/jpet.118.256222
   PubMed Web of Science ®Google Scholar
• Baghy K, Tátrai P, Regős E, Kovalszky I. Proteoglycans in liver cancer. World J Gastroenterol. 2016;22(1):379–393. doi:10.3748/wjg.v22.i1.379
   PubMed Web of Science ®Google Scholar
• Frevert C, Wight TN. Matrix proteoglycans. In: Laurent GJ, editor. The Encyclopedia of Respiratory Medicine. London, UK: Elsevier; 2006:184–187.
   Google Scholar
• Gill S, Wight TN, Frevert CW. Proteoglycans: key regulators of pulmonary inflammation and the innate immune response to lung infection. Anat Rec (Hoboken). 2010;293(6):968–981. doi:10.1002/ar.21094
   PubMedGoogle Scholar
• Taylor KR, Gallo RL. Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J. 2006;20:9–22. doi:10.1096/fj.05-4682rev
   PubMed Web of Science ®Google Scholar
• Coombe DR. Biological implications of glycosaminoglycan interactions with haemopoietic cytokines. Immunol Cell Biol. 2008;86:598–607. doi:10.1038/icb.2008.49
   PubMed Web of Science ®Google Scholar
• Wight TN. Arterial remodeling in vascular disease: a key role for hyaluronan and versican. Front Biosci. 2008;13:4933–4937. doi:10.2741/3052
   PubMedGoogle Scholar
• Takahashi A, Majumdar A, Parameswaran H, et al. Proteoglycans maintain lung stability in an elastase-treated mouse model of emphysema. Am J Respir Cell Mol Biol. 2014;51(1):26–33. doi:10.1165/rcmb.2013-0179OC
   PubMed Web of Science ®Google Scholar
• Kim EK, Choi EJ. Compromised MAPK signaling in human diseases: an update. Arch Toxicol. 2015;89(6):867–882. doi:10.1007/s00204-015-1472-2
   PubMed Web of Science ®Google Scholar
• Sun Y, Liu WZ, Liu T, et al. Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence, and apoptosis. J Recept Signal Transduct Res. 2015;35(6):600–604. doi:10.3109/10799893.2015.1030412
   PubMed Web of Science ®Google Scholar
• Szatmary Z, Garabedian MJ, Vilcek J. Inhibition of glucocorticoid receptor-mediated transcriptional activation by p38 mitogen-activated protein (MAP) kinase. J Biol Chem. 2004;279(42):43708–43715. doi:10.1074/jbc.M406568200
   PubMed Web of Science ®Google Scholar
• Banerjee A, Koziol-White C, Panettieri R Jr. p38 MAPK inhibitors, IKK2 inhibitors, and TNFα inhibitors in COPD. Curr Opin Pharmacol. 2012;12(3):287–292. doi:10.1016/j.coph.2012.01.016
   PubMed Web of Science ®Google Scholar
• De Petris L, Brandén E, Herrmann R, et al. Diagnostic and prognostic role of plasma levels of two forms of cytokeratin 18 in patients with non-small-cell lung cancer. Eur J Cancer. 2011;47(1):131–137. doi:10.1016/j.ejca.2010.08.006
   PubMed Web of Science ®Google Scholar
• Zhang B, Wang J, Liu W, et al. Cytokeratin 18 knockdown decreases cell migration and increases chemosensitivity in non-small cell lung cancer. J Cancer Res Clin Oncol. 2016;142(12):2479–2487. doi:10.1007/s00432-016-2253-x
   PubMed Web of Science ®Google Scholar
• Yi H, Ku NO. Intermediate filaments of the lung. Histochem Cell Biol. 2013;140:65e69. doi:10.1007/s00418-013-1105-x
   Web of Science ®Google Scholar
• Nahm DH, Lee YE, Yim EJ. Identification of cytokeratin 18 as a bronchial epithelial autoantigen associated with nonallergic asthma. Am J Respir Crit Care Med. 2002;165:1536e1539. doi:10.1164/rccm.200201-009OC
   Web of Science ®Google Scholar
• Hacker S, Lambers C, Pollreisz A, et al. Increased soluble serum markers caspase-cleaved cytokeratin-18, histones, and ST2 indicate apoptotic turnover and chronic immune response in COPD. J Clin Lab Anal. 2009;23(6):372–379. doi:10.1002/jcla.20348
   PubMed Web of Science ®Google Scholar
• Lichtenauer M, Zimmermann M, Nickl S, et al. Transient hypoxia leads to increased serum levels of heat shock protein-27, −70 and caspase-cleaved cytokeratin 18. Clin Lab. 2014;60(2):323–328. doi:10.7754/clin.lab.2013.130303
   PubMed Web of Science ®Google Scholar
• Wang Z, Li W, Guo Q, et al. Insulin-like growth Factor-1 signaling in lung development, and inflammatory lung diseases. Biomed Res Int. 2018;2018:6057589. doi:10.1155/2018/6057589
   PubMed Web of Science ®Google Scholar
• Graff JW, Powers LS, Dickson AM, et al. Cigarette smoking decreases global microRNA expression in human alveolar macrophages. PLoS One. 2012;7(8):e44066. doi:10.1371/journal.pone.0044066
   PubMed Web of Science ®Google Scholar
• Wei P, Xie Y, Abel PW, et al. Transforming growth factor (TGF)-beta1-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis. Cell Death Dis. 2019;10:670. doi:10.1038/s41419-019-1873-x
   PubMed Web of Science ®Google Scholar
• Zhao H, Guo Y, Sun Y, et al. miR-181a/b-5p ameliorates inflammatory response in monocrotaline-induced pulmonary arterial hypertension by targeting endocan. J Cell Physiol. 2020;235:4422–4433. doi:10.1002/jcp.29318
   PubMed Web of Science ®Google Scholar
• Duan FG, Wang MF, Cao YB, et al. MicroRNA-421 confers paclitaxel resistance by binding to the KEAP1 30UTR and predicts poor survival in non-small cell lung cancer. Cell Death Dis. 2019;10:1–14. doi:10.1038/s41419-019-2031-1
   Web of Science ®Google Scholar
• Shen W, Liu J, Zhao G, et al. Repression of toll-like receptor-4 by microRNA-149-3p is associated with smoking-related COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:705–715. doi:10.2147/COPD.S128031
   PubMed Web of Science ®Google Scholar
• Di T, Yang Y, Fu C, et al. Let-7 mediated airway remodelling in chronic obstructive pulmonary disease via the regulation of IL-6. Eur J Clin Invest. 2020;9:e13425. doi:10.1111/eci.13425
   Web of Science ®Google Scholar
• Liu S, Liu M, Dong L. The clinical value of lncRNA MALAT1 and its targets miR-125b, miR-133, miR-146a, and miR-203 for predicting disease progression in chronic obstructive pulmonary disease patients. J Clin Lab Anal. 2020;34(9):e23410. doi:10.1002/jcla.23410
   PubMed Web of Science ®Google Scholar
• Shigemura M, Lecuona E, Angulo M, et al. Hypercapnia increases airway smooth muscle contractility via caspase-7-mediated miR-133a-RhoA signaling. Sci Transl Med. 2018;10(457):1662. doi:10.1126/scitranslmed.aat1662
   Web of Science ®Google Scholar
• Pihtili A, Bingol Z, Kiyan E. Serum endocan levels in patients with stable COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:3367–3372. doi:10.2147/COPD.S182731
   PubMed Web of Science ®Google Scholar
• In E, Kuluöztürk M, Turgut T, et al. Endocan as a potential biomarker of disease severity and exacerbations in COPD. Clin Respir J. 2021;15(4):445–453. doi:10.1111/crj.13320
   PubMed Web of Science ®Google Scholar
• Dai L, He J, Chen J, et al. The association of elevated circulating endocan levels with lung function decline in COPD patients. Int J Chron Obstruct Pulmon Dis. 2018;13:3699–3706. doi:10.2147/COPD.S175461
   PubMed Web of Science ®Google Scholar
• Yuan HS, Xiong DQ, Huang F, Cui J, Luo H. MicroRNA-421 inhibition alleviates bronchopulmonary dysplasia in a mouse model via targeting Fgf10. J Cell Biochem. 2019;120:16876–16887. doi:10.1002/jcb.28945
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Oxidative stress-based therapeutics in COPD. Redox Biol. 2020;33:101544. doi:10.1016/j.redox.2020.101544
   PubMed Web of Science ®Google Scholar
• Jing X, Luan Z, Liu B. miR-558 reduces the damage of HBE cells exposed to cigarette smoke extract by targeting TNFRSF1A and inactivating TAK1/MAPK/NF-κB pathway. Immunol Invest. 2021;1–15. doi:10.1080/08820139.2021.1874977
   Web of Science ®Google Scholar
• Li X, Feng Y, Yang B, et al. A novel circular RNA, hsa_circ_0030998 suppresses lung cancer tumorigenesis and Taxol resistance by sponging miR-558. Mol Oncol. 2021;15(8):2235–2248. doi:10.1002/1878-0261.12852
   PubMed Web of Science ®Google Scholar
• Mao Y, He JX, Zhu M, et al. Circ0001320 inhibits lung cancer cell growth and invasion by regulating TNFAIP1 and TPM1 expression through sponging miR-558. Hum Cell. 2021;34(2):468–477. doi:10.1007/s13577-020-00453-4
   PubMed Web of Science ®Google Scholar
• Li XJ, Chen LW, Gao P, et al. MiR-587 acts as an oncogene in non-small-cell lung carcinoma via reducing CYLD expression. Eur Rev Med Pharmacol Sci. 2020;24(24):12741–12747. doi:10.26355/eurrev_202012_24173
   PubMed Web of Science ®Google Scholar
• Tian H, Wang X, Lu J, et al. MicroRNA-621 inhibits cell proliferation and metastasis in bladder cancer by suppressing Wnt/β-catenin signaling. Chem Biol Interact. 2019;308:244–251. doi:10.1016/j.cbi.2019.05.042
   PubMed Web of Science ®Google Scholar
• Wang YH, Yin YW, Zhou H, et al. miR-639 is associated with advanced cancer stages and promotes proliferation and migration of nasopharyngeal carcinoma. Oncol Lett. 2018;16(6):6903–6909. doi:10.3892/ol.2018.9512
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang S, Yin J, Xu R. MiR-566 mediates cell migration and invasion in colon cancer cells by direct targeting of PSKH1. Cancer Cell Int. 2019;19:333. doi:10.1186/s12935-019-1053-1
   PubMed Web of Science ®Google Scholar
• Dai W, Liu S, Zhang J, et al. Vorinostat triggers miR-769-5p/3p-mediated suppression of proliferation and induces apoptosis via the STAT3-IGF1R-HDAC3 complex in human gastric cancer. Cancer Lett. 2021;521:196–209. doi:10.1016/j.canlet.2021.09.001
   PubMed Web of Science ®Google Scholar
• Xie L, Jiang T, Cheng A, et al. MiR-597 targeting 14-3-3σ enhances cellular invasion and EMT in nasopharyngeal carcinoma cells. Curr Mol Pharmacol. 2019;12(2):105–114. doi:10.2174/1874467212666181218113930
   PubMed Web of Science ®Google Scholar